Extended efalizumab therapy improves chronic plaque psoriasis: results from a randomized phase III trial. (Q53785662)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Extended efalizumab therapy improves chronic plaque psoriasis: results from a randomized phase III trial.
scientific article

    Statements

    Extended efalizumab therapy improves chronic plaque psoriasis: results from a randomized phase III trial. (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit